Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Blog
Blog
Share
Blog
Jun 26, 2019
| Jennifer Soup
GRx+Biosims 2019: Register Now and Be Part of the Solution
Blog
Jun 25, 2019
| Erik Komendant
Section 205 is Still Flawed and Erodes the Only Incentive to Challenge Brand-Name Drug Patents. Here’s Why.
Blog
Jun 19, 2019
| Chip Davis
Congress: Don’t Punish American Patients
Blog
May 29, 2019
| Erica Klinger
Five Lessons from a National Collaboration to Promote Prescription Drug Safety
Blog
May 28, 2019
| Jewel Smith
Join AAM Today!
Blog
May 23, 2019
| Erica Klinger
WiHP Event Features Congressional Speaker
Blog
May 13, 2019
| Erica Klinger
Highlights from the NAFTA 2.0 Congressional Briefing: The May 10 Amendments
Blog
May 9, 2019
| AAM
2019 Generic Drug and Biosimilars Access & Savings in the U.S. Report
Blog
Apr 25, 2019
| Allen Goldberg
National Drug Take Back Day Is Saturday: Here’s What You Need to Know
Blog
Apr 23, 2019
| Erica Klinger
Jonnie Is Informed about Generic Prescriptions. How Does Your Knowledge Measure Up?
Blog
Apr 1, 2019
| Jonathan Kimball
NAFTA 2.0: 3 Obstacles to More Affordable Medicines in the U.S.
Blog
Mar 28, 2019
| Erica Klinger
AAM Wins Bronze Award from Association TRENDS
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action